Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:5601593.
doi: 10.1155/2017/5601593. Epub 2017 Mar 14.

ROS: Crucial Intermediators in the Pathogenesis of Intervertebral Disc Degeneration

Affiliations
Review

ROS: Crucial Intermediators in the Pathogenesis of Intervertebral Disc Degeneration

Chencheng Feng et al. Oxid Med Cell Longev. 2017.

Abstract

Excessive reactive oxygen species (ROS) generation in degenerative intervertebral disc (IVD) indicates the contribution of oxidative stress to IVD degeneration (IDD), giving a novel insight into the pathogenesis of IDD. ROS are crucial intermediators in the signaling network of disc cells. They regulate the matrix metabolism, proinflammatory phenotype, apoptosis, autophagy, and senescence of disc cells. Oxidative stress not only reinforces matrix degradation and inflammation, but also promotes the decrease in the number of viable and functional cells in the microenvironment of IVDs. Moreover, ROS modify matrix proteins in IVDs to cause oxidative damage of disc extracellular matrix, impairing the mechanical function of IVDs. Consequently, the progression of IDD is accelerated. Therefore, a therapeutic strategy targeting oxidative stress would provide a novel perspective for IDD treatment. Various antioxidants have been proposed as effective drugs for IDD treatment. Antioxidant supplementation suppresses ROS production in disc cells to promote the matrix synthesis of disc cells and to prevent disc cells from death and senescence in vitro. However, there is not enough in vivo evidence to support the efficiency of antioxidant supplementation to retard the process of IDD. Further investigations based on in vivo and clinical studies will be required to develop effective antioxidative therapies for IDD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The redox homeostasis of intervertebral disc (IVD) cells. The role of the mitochondrion in reactive oxygen species (ROS) generation of disc cells has been well established. During the transportation of electrons, a small proportion of electrons (1%–3%) leak to produce ROS. However, the nonmitochondrial ROS generation through nicotinamide adenine dinucleotide phosphate (NADPH) oxidase or xanthine oxidase in disc cells remains unknown. Thus, “?” is labeled in these pathways. ROS scavenging is performed by antioxidants and detoxicating enzymes.
Figure 2
Figure 2
Disturbed redox homeostasis in the microenvironment of degenerative IVDs. Excessive reactive oxygen species (ROS) production and impaired antioxidative system exist in degenerative discs.
Figure 3
Figure 3
The involvement of reactive oxygen species (ROS)/oxidative stress in the pathogenesis of intervertebral disc (IVD) degeneration (IDD). ROS activate various signaling pathways in IVD cells and consequently regulate the phenotype, apoptosis, autophagy, and senescence of disc cells. Sustained oxidative stress induced by ROS overproduction reinforces matrix degradation and inflammation and enhances the decrease in the number of viable and functional disc cells in IVDs. Furthermore, ROS alter the extracellular matrix (ECM) structure of IVDs through oxidative modification, impairing the mechanical function of IVDs. As a result, the progression of IDD is accelerated. SASP: senescence-associated secretory phenotype.

Similar articles

Cited by

References

    1. Vos T., Flaxman A. D., Naghavi M., et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380(9859):2163–2196. - PMC - PubMed
    1. Hong J., Reed C., Novick D., Happich M. Costs associated with treatment of chronic low back pain: an analysis of the UK general practice research database. Spine. 2013;38(1):75–82. doi: 10.1097/brs.0b013e318276450f. - DOI - PubMed
    1. Cheung K. M. C., Karppinen J., Chan D., et al. Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine. 2009;34(9):934–940. doi: 10.1097/BRS.0b013e3181a01b3f. - DOI - PubMed
    1. Takatalo J., Karppinen J., Niinimäki J., et al. Does lumbar disc degeneration on magnetic resonance imaging associate with low back symptom severity in young finnish adults? Spine. 2011;36(25):2180–2189. doi: 10.1097/BRS.0b013e3182077122. - DOI - PubMed
    1. Roberts S., Evans H., Trivedi J., Menage J. Histology and pathology of the human intervertebral disc. The Journal of Bone & Joint Surgery—American Volume. 2006;88(supplement 2):10–14. doi: 10.2106/jbjs.f.00019. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources